1-4 of 4
Kristen Migliaccio-Walle
Close
Sort by
Journal Articles

10-Year Impact on Productivity Costs Associated with Mortality in Stage III or IV Classical Hodgkin Lymphoma Based on the Overall Survival Update of the ECHELON-1 Trial: Application of an Oncology Simulation Model in the United States

Tycel J. Phillips, Nicholas Liu, Brian Bloudek, Kristen Migliaccio-Walle, Jade Reynolds, John M. Burke
Journal: Blood
Blood (2022) 140 (Supplement 1): 10791–10792.
https://doi.org/10.1182/blood-2022-162573
Published: 2022
Journal Articles

An Oncology Simulation Model to Estimate 10-Year Progression-Free Survival and Stem Cell Transplantation for Frontline, Stage III or IV Classical Hodgkin Lymphoma Based on the 5-Year Update of the ECHELON-1 Trial: A United States Perspective

Tycel Phillips, Kristen Migliaccio-Walle, Kristina S. Yu, Brian Bloudek, Nicholas Liu, Michelle A. Fanale, John M. Burke
Journal: Blood
Blood (2021) 138 (Supplement 1): 2440.
https://doi.org/10.1182/blood-2021-147308
Published: 2021
Journal Articles

Cost-Effectiveness of Deferasirox (Exjade®) Versus No Chelation In Patients with Lower Risk Myelodysplastic Syndromes (MDS): A Canadian Perspective

Khalid El Ouagari, PhD, Kristen Migliaccio-Walle, BS, Helen Lau, MS, Duygu Bozkaya, MBA, MSc
Journal: Blood
Blood (2010) 116 (21): 4962.
https://doi.org/10.1182/blood.V116.21.4962.4962
Published: 2010
Journal Articles

Impact of Management of Iron Overload in Patients with Myelodsplastic Syndromes

Duygu Bozkaya, Kristen Migliaccio-Walle, Jean-Franòois Baladi
Journal: Blood
Blood (2008) 112 (11): 1308.
https://doi.org/10.1182/blood.V112.11.1308.1308
Published: 2008